Patent details

Basic Information

Publication number:

EP0200421

WO Application Number:

Type:

European Patent Granted for NL

Status:

Expired. Art. 36.6 ROW

Publication Title:

Title When Made Available For Viewing:

Reason Lapsed:

Application number:

EP86302855.1

WO Publication Number:

EPO Publication Language:

English

SPC Number:

960017

First Applicant Residence Country:

United States of America (US)

Publications:

Dates

Filing date:

16/04/1986

Grant date:

28/07/1993

EP Publication Date:

28/07/1993

WO Publication Date:

Claims Translations Received Date:

Claims Translation B1 Received Date:

Claims Translation B2 Received Date:

Claims Translation B3 Received Date:

Lapsed By Non Payment Annual Fee Date:

Renunciation Date:

NullificationDate:

Published:

Due To Cession Date:

Registration date:

28/07/1993

EP B1 Publication Date:

28/07/1993

EP B2 Publication Date:

EP B3 Publication Date:

Description Translation B1 Received Date:

Description Translation B2 Received Date:

Description Translation B3 Received Date:

Expiration date:

15/04/2006

Lapsed By Expiration Date:

17/04/2006

Revocation Date:

Invalidity Date:

Response To Novelty Search Report Received:

Patent Granting Request:

Lapsed date:

Applicant/holder

From:

28/07/1993

 

 

 

Name:

ZymoGenetics, Inc.

Address:

-, Seattle, Washington, United States of America (US)

Inventor

1

Name:

Frederick S. Hagen

Address:

Seattle, Washington, United States of America (US)

2

Name:

Mark J. Murray

Address:

Seattle, Washington, United States of America (US)

3

Name:

Sharon, J. Busby

Address:

Seattle, Washington, United States of America (US)

4

Name:

Kathleen L. Berkner

Address:

Seattle, Washington, United States of America (US)

5

Name:

Margaret Y. Insley

Address:

Woodinville, Washington, United States of America (US)

6

Name:

Richard G. Woodbury

Address:

Seattle, Washington, United States of America (US)

7

Name:

Charles L. Gray

Address:

Seattle, Washington, United States of America (US)

Priority

1

Priority Patent Number:

0000810002

Priority Date:

16/12/1985

Priority Country:

United States of America (US)

2

Priority Patent Number:

0000724311

Priority Date:

17/04/1985

Priority Country:

United States of America (US)

Classification

Main IPC Class:

C12N 15/57;

IPC or IDT classification:

C12N 5/10; C12N 9/64;

Publication

Bulletin

1

Bulletin Heading:

VRV

Journal edition number:

2006/06

Publication date:

01/06/2006

Description:

Lapse or annulment

2

Bulletin Heading:

EP3

Journal edition number:

1994/01

Publication date:

03/01/1994

Description:

European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

3

Bulletin Heading:

EP2

Journal edition number:

1993/18

Publication date:

16/09/1993

Description:

European patents granted for the Netherlands

Deed

Special Item

Change Kind/ Decision Type:

Deed Number:

48357-A048357-1

Date Registered:

31/07/2006

License Effective Date:

License Expiration Date:

Scope of License:

Deed Filer:

ir. M.F.J.M. Ketelaars c.s.

Journal Edition Number:

Text:

Bijzonder stuk met aktenummer 48357, ingediend op 31 juli 2006 door het Nederlandsch Octrooibureau, waarin op verzoek van het Nederlandsch Octrooibureau in het register wordt aangetekend dat Zymogenetics, Inc. te Seattle, Washington, Verenigde Staten van Amerika als de houder van SPC 960017, behorend bij EPNL 0200421, haar rechten heeft overgedragen aan Novo Nordisk Health Care AG te Kusnacht, Zwitserland. Zie verder akte.

Deed Status:

Country Code:

Updated License Number:

Terminated License Number:

Changed Pledgee

Name:

Address:

Removed Usufructuary

Name:

Address:

Added Usufructuary

Name:

Address:

Changed Usufructuary

Name:

Address:

	Filing date	Document type	Document Description	Number of pages	File Type